Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01222182 · ClinicalTrials.gov registry record
Statin Interchange by Pharmacist Collaborative Practice Agreement (CPA)
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 260
- Enrollment target
NCT01222182: Completed study, sponsored by Mayo Clinic.
NCT01222182 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 260 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01222182 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 260 participants
- Enrollment target
Study Summary
A group of \~ 225 patients were switched from atorvastatin to an equivalent statin either by their physicians usual management or by an collaborative pharmacist coordinated process. We will compare the results of pharmacist process to the standard medical practice to find potentially which process is more effective, safer and efficient. We are surveying a total of 35 physicians, 12 using the pharmacist coordinated process and 23 not, comparing their satisfaction of the 2 processes.
Primary Outcome
We compared doses selected for therapeutic equivalency for the new statin Did the process result in selecting a safe and effective statin alternative?
Interventions
- DRUG atorvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-06 |
What the finished NCT01222182 record still lists
NCT01222182 is an observational study that tracks outcomes without assigning an intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which atorvastatin is the first listed.
NCT01222182 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01222182 about?
NCT01222182 is a clinical study titled "Statin Interchange by Pharmacist Collaborative Practice Agreement (CPA)". A group of \~ 225 patients were switched from atorvastatin to an equivalent statin either by their physicians usual management or by an collaborative pharmacist coordinated process. We will compare the results of pharmacist process to the standard medical practice to find potentially which process i...
What is the current status of trial NCT01222182?
This trial is currently completed. The enrollment target is 260 participants. The study started on 2009-09. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01222182?
The interventions under investigation include: atorvastatin (DRUG).
Who is sponsoring clinical trial NCT01222182?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia